Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal AST-726 for Migraine Prophylaxis
NCT00285402Phase 2Unknown
- Sponsor
- Ariston Pharmaceuticals, Inc.
- Start
- May 2007
- Primary completion
- Jun 2008
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 3
01
Overview
A Phase 2 trial of AST-726 in migraine, sponsored by Ariston Pharmaceuticals, Inc.. Status: unknown.
02
Drugs
AST-726
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00285402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00285402.